{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:47:00Z","timestamp":1732031220174},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":5109,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1046\/j.1469-0691.8.s.3.2.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T12:28:30Z","timestamp":1047385710000},"page":"9-20","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S3","title":["The era of antimicrobial resistance\u2014implications for the clinical laboratory"],"prefix":"10.1016","volume":"8","author":[{"given":"D.E.","family":"Low","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib1","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.286.15.1857","article-title":"Macrolide resistance among invasive Streptococcus pneumoniae isolates","volume":"286","author":"Hyde","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib2","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/AAC.43.10.2510","article-title":"Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates","volume":"43","author":"Oster","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/10766290152652837","article-title":"Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997\u201399)","volume":"7","author":"Marchese","year":"2001","journal-title":"Microb Drug Resist"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/45.4.457","article-title":"Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997\u201398","volume":"45","author":"Sahm","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/JCM.37.4.897-901.1999","article-title":"Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan","volume":"37","author":"Hsueh","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.46.5.1295-1301.2002","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000","volume":"46","author":"Low","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u201395","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1128\/JCM.39.4.1311-1315.2001","article-title":"Differentiation of resistance phenotypes among erythromycin-resistant pneumococci","volume":"39","author":"Montanari","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib9","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.42.9.2425","article-title":"Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae","volume":"42","author":"Johnston","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/AAC.35.7.1267","article-title":"Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification","volume":"35","author":"Leclercq","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.40.8.1817","article-title":"Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib12","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/AAC.45.7.2147-2150.2001","article-title":"Macrolide-resistant Streptococcus pneumoniae in Canada during 1998\u201399. Prevalence of mef (a) and erm (B) and susceptibilities to ketolides. Antimicrob","volume":"45","author":"Hoban","year":"2001","journal-title":"Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib13","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1128\/AAC.45.9.2427-2431.2001","article-title":"In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms","volume":"45","author":"Morosini","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib14","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/AAC.43.12.2823","article-title":"Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants","volume":"43","author":"Roberts","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib15","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/AAC.45.5.1578-1580.2001","article-title":"Macrolide resistance in Streptococcus pneumoniae in Hong Kong","volume":"45","author":"Ip","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib16","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/AAC.45.5.1595-1598.2001","article-title":"Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm (B) and mef (A) in South Africa","volume":"45","author":"McGee","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/jac\/43.5.637","article-title":"Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics","volume":"43","author":"Nishijima","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib18","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/AAC.40.9.2190","article-title":"Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network","volume":"40","author":"Simor","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/PL00011229","article-title":"Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque","volume":"19","author":"Angot","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/45.1.119","article-title":"Macrolide resistance in Belgian Streptococcus pneumoniae","volume":"45","author":"Lagrou","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/jac\/42.6.729","article-title":"Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates","volume":"42","author":"Klugman","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib22","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/315853","article-title":"The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment","volume":"182","author":"Gay","year":"2000","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1046\/j.1469-0691.8.s.3.2.x_bib23","first-page":"S27","article-title":"Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia","volume":"34","author":"Lynch","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u201397","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/32.6.885","article-title":"Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland","volume":"32","author":"Seppala","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","article-title":"Drug-resistant Streptococcus pneumoniae","volume":"26","author":"Campbell","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-199901000-00002","article-title":"Acute otitis media: management and surveillance in an era of pneumococcal resistance \u2013 a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"18","author":"Dowell","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199958010-00001","article-title":"Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem","volume":"58","author":"Klugman","year":"1999","journal-title":"Drugs"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/516340","article-title":"Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children","volume":"26","author":"Choi","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1542\/peds.102.6.1369","article-title":"Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae","volume":"102","author":"Tan","year":"1998","journal-title":"Pediatrics"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib32","series-title":"Performance standards for antimicrobial susceptibility testing; Eleventh informational Suppl. M100\u2013S11","author":"National Committee for Clinical Laboratory Standards","year":"2001"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1128\/JCM.40.2.669-674.2002","article-title":"In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100\u2013S12 recommendations","volume":"40","author":"Sahm","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib35","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.41.9.1965","article-title":"A multicenter, radomized study comparing the efficacy and safety of intravenous and\/or oral levofloxacin versus ceftriaxone and\/or cefuroxime axetil in treatment of adults with community-acquired pneumonia","volume":"41","author":"File","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib36","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib38","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.119.1.185","article-title":"Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults","volume":"119","author":"Petitpretz","year":"2001","journal-title":"Chest"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/AAC.46.3.680-688.2002","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994\u201395","volume":"46","author":"Brueggemann","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib41","first-page":"800","article-title":"Resistance of Streptococcus pneumoniae to fluoroquinolones\u2014United States, 1995\u201399","volume":"50","author":"Centers for Disease Control","year":"2001","journal-title":"Morbid Mortal Weekly Report"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/48.5.659","article-title":"Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000","volume":"48","author":"Ho","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib44","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/AAC.45.12.3334-3340.2001","article-title":"Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998\u201399) multicenter surveillance study in Spain","volume":"45","author":"Perez-Trallero","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/AAC.45.4.1037-1042.2001","article-title":"Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis","volume":"45","author":"Sahm","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib46","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/514934","article-title":"Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group","volume":"27","author":"Chodosh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.10229","article-title":"Levofloxacin failure in a patient with pneumococcal pneumonia","volume":"35","author":"Empey","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1592\/phco.22.5.395.33185","article-title":"Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia","volume":"22","author":"Kays","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-131-4-199908170-00023","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"131","author":"Kuehnert","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib51","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/323086","article-title":"Fluoroquinoloneresistant Streptococcus pneumoniae associated with levofloxacin therapy","volume":"184","author":"Urban","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/322658","article-title":"A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae","volume":"33","author":"Weiss","year":"2001","journal-title":"Clin Inf Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib53","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/AAC.44.9.2521-2524.2000","article-title":"Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States","volume":"44","author":"Sahm","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib54","unstructured":"Gillespie SH, Dickens A. Variation in mutation rate of quinolone resistance in Streptococcus pneumoniae. In: American Society for Microbiology 3rd International Symposium on Pneumococci and Pneumococcal Disease. Anchorage, Alaska, May 2002."},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/AAC.46.2.522-524.2002","article-title":"Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin","volume":"46","author":"Li","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/45.5.583","article-title":"Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones","volume":"45","author":"Pestova","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM200207043470115","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"347","author":"Ross","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib58","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/AAC.44.11.3049-3054.2000","article-title":"Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance","volume":"44","author":"Bast","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib59","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/JCM.39.7.2719-2721.2001","article-title":"Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae","volume":"39","author":"Millichap","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib60","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1128\/AAC.45.6.1911-1914.2001","article-title":"Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae","volume":"45","author":"Richardson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib61","unstructured":"Tang P, Green K, Mcgeer A et al. Antibiotic resistance trends in Canadian strains of Streptococcus pneumoniae \u2013 results from 9 consecutive years of surveillance. In: American Society for Microbiology 42nd Interscience Congress Antimicrobial Agents and Chemotherapy. San Diego, California, September 2002."},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib62","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF02013995","article-title":"Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis","volume":"5","author":"Davies","year":"1986","journal-title":"Eur J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/18.3.407","article-title":"Ciprofloxacin in acute exacerbations of chronic bronchitis","volume":"18","author":"Hoogkamp-Korstanje","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1046\/j.1469-0691.8.s.3.2.x_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2165\/00003495-198700341-00016","article-title":"The use of quinolones in respiratory tract infections","volume":"34","author":"Maesen","year":"1987","journal-title":"Drugs"},{"issue":"Suppl. 1","key":"10.1046\/j.1469-0691.8.s.3.2.x_bib66","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1093\/clinids\/10.Supplement_1.S212","article-title":"Quinolones in the treatment of bronchopulmonary infections","volume":"10","author":"Thys","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0002-9343(89)80838-1","article-title":"Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia","volume":"87","author":"Cooper","year":"1989","journal-title":"Am J Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib68","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9343(90)90355-H","article-title":"Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin","volume":"89","author":"Gordon","year":"1990","journal-title":"Am J Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib69","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199108153250719","article-title":"Infectious complications with respiratory pathogens despite ciprofloxacin therapy","volume":"325","author":"Lee","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.8.s.3.2.x_bib70","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/BF01967510","article-title":"Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin","volume":"9","author":"Perez-Trallero","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15600957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15600957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T18:04:00Z","timestamp":1584468240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15600957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":70,"alternative-id":["S1198743X15600957"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.8.s.3.2.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}